However, unlike small molecule CA XII inhibitors, co-treatment of 6A10 with chemotherapy did not overcome resistance in a xenograft model generated with primary triple negative MDA-MB-231 breast cancer cells[77]. This evidence concerns the gene CA12 and breast cancer.